Research Article
FCGR3A Is a Prognostic Biomarker and Correlated with Immune Infiltrates in Lower-Grade Glioma
Table 1
Correlation analysis between FCGR3A and related genes and markers of immune cells in LGG using TIMER and GEPIA databases.
| Description | Gene markers | LGG (TIMER) | LGG (GEPIA) | None | Purity | cor | | cor | | R | |
| CD8+T cell | CD8A | 0.2719 | | 0.2843 | | 0.3 | | CD8B | 0.2471 | | 0.2713 | | 0.26 | | T cell (general) | CD3D | 0.5282 | | 0.5476 | | 0.49 | | CD3E | 0.5893 | | 0.6117 | | 0.6 | | CD2 | 0.5923 | | 0.6058 | | 0.61 | | B cell | CD19 | 0.4395 | | 0.4341 | | 0.55 | | CD79A | 0.3709 | | 0.3921 | | 0.38 | | Monocyte | CD86 | 0.7949 | | 0.8023 | | 0.8 | | CSF1R | 0.6704 | | 0.6720 | | 0.67 | | TAM | CCL2 | 0.5687 | | 0.5589 | | 0.58 | | CD68 | 0.7838 | | 0.7931 | | 0.78 | | PD-L1 (CD274) | 0.4561 | | 0.4616 | | 0.54 | | PD-L2 (PDCD1LG2) | 0.7379 | | 0.7469 | | 0.74 | | IL10 | 0.6571 | | 0.6514 | | 0.65 | | M1 macrophage | INOS (NOS2) | −0.1623 | | −0.1449 | | −0.15 | | IRF5 | 0.7079 | | 0.7169 | | 0.7 | | COX2 (PTGS2) | 0.1645 | | 0.1566 | | 0.21 | | M2 macrophage | CD163 | 0.5708 | | 0.5581 | | 0.56 | | VSIG4 | 0.7058 | | 0.7030 | | 0.71 | | MS4A4A | 0.6396 | | 0.6444 | | 0.65 | | Neutrophils | CD66b (CEACAM8) | 0.0304 | 0.4902 | 0.0232 | 0.6131 | 0.03 | 0.5000 | CD11b (ITGAM) | 0.7129 | | 0.7152 | | 0.71 | | CCR7 | 0.4100 | | 0.4265 | | 0.42 | | Natural killer cell | KIR2DL1 | 0.0730 | 0.0977 | 0.0914 | | 0.14 | | KIR2DL3 | 0.2595 | | 0.2808 | | 0.26 | | KIR2DL4 | 0.4566 | | 0.4752 | | 0.49 | | KIR3DL1 | 0.0670 | 0.1284 | 0.0715 | 0.1182 | 0.15 | | KIR3DL2 | 0.1890 | | 0.2042 | | 0.2 | | KIR3DL3 | 0.0562 | 0.2023 | 0.0362 | 0.4287 | 0.057 | 0.1900 | KIR2DS4 | 0.2158 | | 0.2379 | | 0.22 | | Dendritic cell | HLA-DPB1 | 0.7614 | | 0.7645 | | 0.77 | | HLA-DQB1 | 0.6223 | | 0.6245 | | 0.51 | | HLA-DRA | 0.8060 | | 0.8044 | | 0.81 | | HLA-DPA1 | 0.7780 | | 0.7813 | | 0.78 | | BDCA-1 (CD1C) | 0.4226 | | 0.4342 | | 0.45 | | BDCA-4 (NRP1) | 0.3271 | | 0.3277 | | 0.32 | | CD11c (ITGAX) | 0.5944 | | 0.6012 | | 0.57 | | Th1 | T-bet (TBX21) | 0.3742 | | 0.3753 | | 0.41 | | STAT4 | −0.1408 | | −0.1228 | | −0.098 | | STAT1 | 0.5176 | | 0.5159 | | 0.54 | | IFN-γ (IFNG) | 0.2490 | | 0.2547 | | 0.28 | | TNF-α (TNF) | 0.2990 | | 0.2856 | | 0.32 | | Th2 | GATA3 | 0.4229 | | 0.4314 | | 0.4 | | STAT6 | 0.4826 | | 0.5005 | | 0.5 | | STAT5A | 0.6670 | | 0.6630 | | 0.67 | | IL13 | −0.0299 | 0.4986 | −0.0314 | 0.4923 | 0.0039 | 0.93 | Tfh | BCL6 | 0.1152 | | 0.0834 | 0.0681 | 0.1500 | | IL21 | 0.1336 | | 0.1174 | | 0.21 | | Th17 | STAT3 | 0.5832 | | 0.5700 | | 0.57 | | IL17A | 0.0141 | 0.7500 | −0.0082 | 0.8571 | 0.0200 | 0.6500 | Treg | FOXP3 | −0.1947 | | −0.1748 | | −0.14 | | CCR8 | 0.1704 | | 0.1853 | | 0.21 | | STAT5B | −0.0002 | 0.9962 | −0.0272 | 0.5532 | 0.038 | 0.38 | TGFβ (TGFB1) | 0.6535 | | 0.6578 | | 0.66 | | T cell exhaustion | PD-1 (PDCD1) | 0.5345 | | 0.5401 | | 0.54 | | CTLA4 | 0.4502 | | 0.4482 | | 0.45 | | LAG3 | 0.2541 | | 0.2590 | | 0.23 | | TIM-3 (HAVCR2) | 0.8174 | | 0.8231 | | 0.82 | | GZMB | 0.3520 | | 0.3627 | | 0.36 | |
|
|
LGG: brain lower grade glioma; TAM: tumor-associated macrophage; Th: T helper cell; Tfh: follicular helper T cell; Treg: regulatory T cell; Cor: R-value of Spearman’s correlation; none: correlation without adjustment. Purity: correlation adjusted by purity. -value significant codes: 0 ≤ <0.001 ≤ <0.01 ≤ <0.05 ≤. |